Product Code: ETC8855040 | Publication Date: Sep 2024 | Updated Date: Jun 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The xerostomia (dry mouth) therapeutics market is gradually growing in the Philippines, driven by aging populations and rising diabetes and cancer treatments that cause dry mouth. Product offerings include saliva substitutes, mouthwashes, and prescription drugs.
The market for xerostomia (dry mouth) therapeutics in the Philippines is gradually growing as more cases of chronic dry mouth are identified among the aging population and patients undergoing treatments such as chemotherapy or radiotherapy. Saliva substitutes, mouth moisturizers, and prescription medications like pilocarpine are commonly used. Dental professionals and oncologists are increasingly recognizing xerostomia as a quality-of-life issue, encouraging a multidisciplinary approach to management. Public awareness, however, remains limited, and this restrains broader market expansion.
The xerostomia (dry mouth) therapeutics market in the Philippines is challenged by underdiagnosis of the condition, particularly among the elderly and individuals undergoing cancer treatment. Low awareness about treatment options and limited availability of specialized oral care products restrict patient access. Additionally, healthcare professionals often prioritize underlying causes over symptom-specific treatments. Pricing sensitivity and a lack of reimbursement also limit the use of premium therapeutic products.
The xerostomia therapeutics market in the Philippines offers investment potential through OTC saliva substitutes, prescription drugs, and supportive oral care products. Given the growing population with diabetes, cancer undergoing radiotherapy, and autoimmune conditions, demand for dry mouth treatments is increasing. Investors can also explore online pharmacy distribution and partnerships with dental clinics for specialized product recommendations.
Healthcare policies promote the availability of therapeutics for conditions like xerostomia (dry mouth) through the inclusion of essential medicines in public health programs. The DOH supports diagnostic and treatment capabilities in hospitals and clinics, backed by regulatory oversight of pharmaceutical products to ensure safety and efficacy.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Xerostomia Therapeutics Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Xerostomia Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Xerostomia Therapeutics Market - Industry Life Cycle |
3.4 Philippines Xerostomia Therapeutics Market - Porter's Five Forces |
3.5 Philippines Xerostomia Therapeutics Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Philippines Xerostomia Therapeutics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.7 Philippines Xerostomia Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Philippines Xerostomia Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Xerostomia Therapeutics Market Trends |
6 Philippines Xerostomia Therapeutics Market, By Types |
6.1 Philippines Xerostomia Therapeutics Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Xerostomia Therapeutics Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Philippines Xerostomia Therapeutics Market Revenues & Volume, By Artificial saliva, 2021- 2031F |
6.1.4 Philippines Xerostomia Therapeutics Market Revenues & Volume, By Dentifrices, 2021- 2031F |
6.1.5 Philippines Xerostomia Therapeutics Market Revenues & Volume, By Salivary Stimulants, 2021- 2031F |
6.1.6 Philippines Xerostomia Therapeutics Market Revenues & Volume, By Saliva Substitutes, 2021- 2031F |
6.1.7 Philippines Xerostomia Therapeutics Market Revenues & Volume, By Drugs and Salivary Pen, 2021- 2031F |
6.2 Philippines Xerostomia Therapeutics Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Philippines Xerostomia Therapeutics Market Revenues & Volume, By Hospital pharmacies, 2021- 2031F |
6.2.3 Philippines Xerostomia Therapeutics Market Revenues & Volume, By Retail pharmacies, 2021- 2031F |
6.2.4 Philippines Xerostomia Therapeutics Market Revenues & Volume, By Online pharmacies, 2021- 2031F |
6.3 Philippines Xerostomia Therapeutics Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Philippines Xerostomia Therapeutics Market Revenues & Volume, By Over the Counter (OTC), 2021- 2031F |
6.3.3 Philippines Xerostomia Therapeutics Market Revenues & Volume, By Prescription, 2021- 2031F |
7 Philippines Xerostomia Therapeutics Market Import-Export Trade Statistics |
7.1 Philippines Xerostomia Therapeutics Market Export to Major Countries |
7.2 Philippines Xerostomia Therapeutics Market Imports from Major Countries |
8 Philippines Xerostomia Therapeutics Market Key Performance Indicators |
9 Philippines Xerostomia Therapeutics Market - Opportunity Assessment |
9.1 Philippines Xerostomia Therapeutics Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Philippines Xerostomia Therapeutics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.3 Philippines Xerostomia Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Philippines Xerostomia Therapeutics Market - Competitive Landscape |
10.1 Philippines Xerostomia Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Philippines Xerostomia Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |